Manufacturer record
Cadila Pharmaceuticals Ltd. Indst. Growth Centre: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Cadila Pharmaceuticals Ltd. Indst. Growth Centre (Jammu & Kashmir) were declared Not of Standard Quality between September 2019 and September 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Cadila Pharmaceuticals Ltd. Indst. Growth Centre in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Chloramphenicol Capsules I.P. 250 mg. (Starphenicol 250) | JK18002Mfg 2019-03 · Exp 2020-02 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.